• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用[11C]FLB 457正电子发射断层扫描(PET)测量哌甲酯引起的纹状体外多巴胺浓度变化。

Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.

作者信息

Montgomery Andrew J, Asselin Marie-Claude, Farde Lars, Grasby Paul M

机构信息

MRC Clinical Sciences Centre, Cyclotron Building, Imperial College, Hammersmith Hospital, London, UK.

出版信息

J Cereb Blood Flow Metab. 2007 Feb;27(2):369-77. doi: 10.1038/sj.jcbfm.9600339. Epub 2006 May 10.

DOI:10.1038/sj.jcbfm.9600339
PMID:16685253
Abstract

[(11)C]FLB 457 is a very high-affinity radiotracer that allows the measurement of dopamine D(2/3) receptor availability in regions of the brain where densities are very low, such as the cerebral cortex. It is not known if [(11)C]FLB 457 binding is sensitive to the concentration of endogenous dopamine in humans in a manner analogous to [(11)C]raclopride and [(123)I]IBZM in the striatum. To test this possibility, extrastriatal [(11)C]FLB 457 binding was measured at baseline and after the oral administration of 40 to 60 mg of the psychostimulant methylphenidate (MP) in 12 healthy volunteers using positron emission tomography (PET) in a balanced-order, double-blind design. The dynamic PET data were quantified using a two-tissue compartment model with a metabolite-corrected arterial plasma input function. Two volunteers were excluded because of excessive head movement. In the remainder, MP caused significant reductions in the volume of distribution (VD) in temporal and frontal cortical regions and thalamus, suggesting that [(11)C]FLB 457 binding is sensitive to endogenous dopamine concentration. Moreover, the change in [(11)C]FLB 457 binding after MP correlated with the dose of MP (in mg/kg body weight) in all regions assessed. We conclude that MP in doses within the therapeutic range for the treatment of attention deficit hyperactivity disorder causes increases in dopamine concentrations in extrastriatal regions and that [(11)C]FLB 457 PET may be a useful tool for the assessment of change in dopamine concentration in these areas in humans.

摘要

[(11)C]FLB 457是一种高亲和力放射性示踪剂,可用于测量大脑中密度极低区域(如大脑皮层)的多巴胺D(2/3)受体可用性。目前尚不清楚[(11)C]FLB 457结合是否像纹状体中的[(11)C]雷氯必利和[(123)I]IBZM那样,对人体内源性多巴胺浓度敏感。为了验证这种可能性,采用正电子发射断层扫描(PET)的平衡顺序双盲设计,对12名健康志愿者在基线状态下以及口服40至60毫克精神兴奋剂哌甲酯(MP)后,测量其纹状体以外区域的[(11)C]FLB 457结合情况。使用具有代谢物校正动脉血浆输入函数的双组织室模型对动态PET数据进行定量分析。两名志愿者因头部运动过度被排除。在其余志愿者中,MP导致颞叶、额叶皮质区域和丘脑的分布容积(VD)显著降低,这表明[(11)C]FLB 457结合对内源性多巴胺浓度敏感。此外,在所有评估区域中,MP给药后[(11)C]FLB 457结合的变化与MP剂量(以毫克/千克体重计)相关。我们得出结论,治疗注意力缺陷多动障碍的治疗范围内剂量的MP会导致纹状体以外区域多巴胺浓度升高,并且[(11)C]FLB 457 PET可能是评估人类这些区域多巴胺浓度变化的有用工具。

相似文献

1
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.使用[11C]FLB 457正电子发射断层扫描(PET)测量哌甲酯引起的纹状体外多巴胺浓度变化。
J Cereb Blood Flow Metab. 2007 Feb;27(2):369-77. doi: 10.1038/sj.jcbfm.9600339. Epub 2006 May 10.
2
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.安非他明诱导的人类皮质多巴胺释放的正电子发射断层扫描成像:高亲和力多巴胺 D2/3 放射性示踪剂[11C]FLB 457 和[11C]法螺必利的比较评估
Synapse. 2009 Jun;63(6):447-61. doi: 10.1002/syn.20628.
3
No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.多巴胺耗竭对人皮质中高亲和力 D2/3 放射性配体 [11C]FLB 457 结合的影响。
Synapse. 2010 Dec;64(12):879-85. doi: 10.1002/syn.20806.
4
Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.使用超高亲和力多巴胺D2/D3受体配体[11C]FLB 457对PET研究进行定量分析:重新评估使用小脑参考区域的有效性。
J Cereb Blood Flow Metab. 2007 Feb;27(2):378-92. doi: 10.1038/sj.jcbfm.9600340. Epub 2006 May 24.
5
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.右旋苯丙胺对纹状体外多巴胺D2/D3受体的影响:一项在健康受试者中使用[11C]FLB 457进行的随机、双盲、安慰剂对照PET研究。
Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):475-83. doi: 10.1007/s00259-008-0969-9. Epub 2008 Nov 5.
6
Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.测量吸烟引起的皮质多巴胺释放:一项[¹¹C]FLB - 457正电子发射断层扫描研究。
Neuropsychopharmacology. 2015 May;40(6):1417-27. doi: 10.1038/npp.2014.327. Epub 2014 Dec 15.
7
Failure to detect amphetamine-induced dopamine release in the cortex with [ C]FLB 457 positron emission tomography (PET): Methodological considerations.使用[C]FLB 457正电子发射断层扫描(PET)未能检测到皮质中苯丙胺诱导的多巴胺释放:方法学考量。
Synapse. 2018 Sep;72(9):e22037. doi: 10.1002/syn.22037. Epub 2018 Jul 13.
8
Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.内源性多巴胺对通过正电子发射断层扫描(PET)测量的纹状体外[¹¹C]FLB 457结合的影响。
Synapse. 2001 Aug;41(2):87-95. doi: 10.1002/syn.1063.
9
The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.劳拉西泮对纹状体外多巴胺D(2/3)受体的影响——一项双盲随机安慰剂对照PET研究。
Psychiatry Res. 2009 Nov 30;174(2):130-7. doi: 10.1016/j.pscychresns.2009.04.006.
10
Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.[11C]FLB 457与人脑纹状体以外多巴胺受体结合的定量分析。
J Cereb Blood Flow Metab. 1999 Oct;19(10):1164-73. doi: 10.1097/00004647-199910000-00013.

引用本文的文献

1
Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective.哌甲酯作为物质使用障碍的一种治疗选择:一种跨诊断视角
Front Psychiatry. 2023 Aug 3;14:1208120. doi: 10.3389/fpsyt.2023.1208120. eCollection 2023.
2
Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder.针对成年注意力缺陷多动障碍患者的正电子发射断层扫描研究。
Jpn J Radiol. 2023 Apr;41(4):382-392. doi: 10.1007/s11604-022-01368-w. Epub 2022 Dec 8.
3
Radiosynthesis and characterization of [F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism.
[F]BS224 的放射性合成与表征:一种对 rs6971 多态性不敏感的新一代 TSPO PET 配体。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):110-124. doi: 10.1007/s00259-021-05617-4. Epub 2021 Nov 16.
4
Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour.多巴胺能和去甲肾上腺素能对与目标导向行为相关的应激诱导的大脑激活变化的调节。
J Psychopharmacol. 2021 Dec;35(12):1449-1463. doi: 10.1177/02698811211044679. Epub 2021 Sep 14.
5
Methods for Quantifying Neurotransmitter Dynamics in the Living Brain With PET Imaging.利用正电子发射断层扫描(PET)成像对活体大脑中神经递质动力学进行定量分析的方法。
Front Physiol. 2020 Jul 21;11:792. doi: 10.3389/fphys.2020.00792. eCollection 2020.
6
Striatal Dopamine Release in Response to Morphine: A [C]Raclopride Positron Emission Tomography Study in Healthy Men.纹状体多巴胺对吗啡的释放:健康男性[C]放射性配体正电子发射断层扫描研究。
Biol Psychiatry. 2019 Sep 1;86(5):356-364. doi: 10.1016/j.biopsych.2019.03.965. Epub 2019 Mar 15.
7
Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.初步数据表明,在精神病谱系中,应激诱导的前额叶多巴胺释放与海马体TSPO表达之间存在联系。
Schizophr Res. 2019 Nov;213:80-86. doi: 10.1016/j.schres.2018.10.008. Epub 2018 Nov 6.
8
Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.精神分裂症患者认知任务时前额叶皮质多巴胺释放减少:一项 [11C]FLB 457 正电子发射断层扫描研究。
Schizophr Bull. 2019 Apr 25;45(3):670-679. doi: 10.1093/schbul/sby076.
9
Failure to detect amphetamine-induced dopamine release in the cortex with [ C]FLB 457 positron emission tomography (PET): Methodological considerations.使用[C]FLB 457正电子发射断层扫描(PET)未能检测到皮质中苯丙胺诱导的多巴胺释放:方法学考量。
Synapse. 2018 Sep;72(9):e22037. doi: 10.1002/syn.22037. Epub 2018 Jul 13.
10
Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.精神分裂症患者皮质应激调节紊乱,但精神病高危临床患者无此现象。
Brain. 2018 Jul 1;141(7):2213-2224. doi: 10.1093/brain/awy133.